glyc-101
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00656474)
Timeline
Indications
Studied for
Mechanism of action
- DNA topoisomerase IINHIBITOR
TOP1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glyc-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00792688 | Phase 2 | Oct 1, 2008 | Glycotex, Inc., The Clinical Testing Center of Beverly Hills |
| NCT00656474 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Glycotex, Inc., The Clinical Testing Center of Beverly Hills |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Glycotex, Inc. | For profit | 2 | 2 | 1 | 2008 |
| The Clinical Testing Center of Beverly Hills | For profit | 2 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1